View in EDS

SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics.

Saved in:
Bibliographic Details
Title: SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics.
Authors: Basso AD; Department of Oncology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07093, USA. andrea.basso@merck.com, Liu M, Dai C, Gray K, Nale L, Tevar S, Lee S, Liang L, Ponery A, Yaremko B, Smith E, Tang H, Sheth PR, Siddiqui MA, Hicklin DJ, Kirschmeier P
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2010 Nov; Vol. 9 (11), pp. 2993-3002. Date of Electronic Publication: 2010 Oct 26.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20978164
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Basso+AD%22">Basso AD</searchLink>; Department of Oncology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07093, USA. andrea.basso@merck.com<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink><br /><searchLink fieldCode="AU" term="%22Dai+C%22">Dai C</searchLink><br /><searchLink fieldCode="AU" term="%22Gray+K%22">Gray K</searchLink><br /><searchLink fieldCode="AU" term="%22Nale+L%22">Nale L</searchLink><br /><searchLink fieldCode="AU" term="%22Tevar+S%22">Tevar S</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink><br /><searchLink fieldCode="AU" term="%22Liang+L%22">Liang L</searchLink><br /><searchLink fieldCode="AU" term="%22Ponery+A%22">Ponery A</searchLink><br /><searchLink fieldCode="AU" term="%22Yaremko+B%22">Yaremko B</searchLink><br /><searchLink fieldCode="AU" term="%22Smith+E%22">Smith E</searchLink><br /><searchLink fieldCode="AU" term="%22Tang+H%22">Tang H</searchLink><br /><searchLink fieldCode="AU" term="%22Sheth+PR%22">Sheth PR</searchLink><br /><searchLink fieldCode="AU" term="%22Siddiqui+MA%22">Siddiqui MA</searchLink><br /><searchLink fieldCode="AU" term="%22Hicklin+DJ%22">Hicklin DJ</searchLink><br /><searchLink fieldCode="AU" term="%22Kirschmeier+P%22">Kirschmeier P</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2010 Nov; Vol. 9 (11), pp. 2993-3002. <i>Date of Electronic Publication: </i>2010 Oct 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20978164
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-10-0548
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2993
    Titles:
      – TitleFull: SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Basso AD
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Dai C
      – PersonEntity:
          Name:
            NameFull: Gray K
      – PersonEntity:
          Name:
            NameFull: Nale L
      – PersonEntity:
          Name:
            NameFull: Tevar S
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Liang L
      – PersonEntity:
          Name:
            NameFull: Ponery A
      – PersonEntity:
          Name:
            NameFull: Yaremko B
      – PersonEntity:
          Name:
            NameFull: Smith E
      – PersonEntity:
          Name:
            NameFull: Tang H
      – PersonEntity:
          Name:
            NameFull: Sheth PR
      – PersonEntity:
          Name:
            NameFull: Siddiqui MA
      – PersonEntity:
          Name:
            NameFull: Hicklin DJ
      – PersonEntity:
          Name:
            NameFull: Kirschmeier P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2010 Nov
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1